The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.

The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.

Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.

The US FDA has granted 510(k) clearance for Exactech’s Equinoxe Scapula Reconstruction System for acromial and scapular spine fractures.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

Carmat has filed for insolvency and requested that the Versailles Economic Affairs Court place it in a receivership.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.